Fingerprint
Dive into the research topics of 'Rituximab for IgG4-related disease: A prospective, open-label trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Rituximab for IgG4-related disease: A prospective, open-label trial
Mollie N. Carruthers, Mark D. Topazian, Arezou Khosroshahi, Thomas E. Witzig, Zachary S. Wallace, Philip A. Hart, Vikram Deshpande, Thomas C. Smyrk, Suresh Chari, John H. Stone, Tore K. Kvien
Research output: Contribution to journal › Article › peer-review
316
Scopus
citations